TickerFacts.

Tonix Pharmaceuticals Holding Corp. (TNXP): Share Repurchases

Annual figures by period end, from SEC filings.

$13.76M
Year ended 2025-12-31
$13.96M2023-12-31: $13.96M2025-12-31: $13.76M$13.76M
2023-12-31 Share Repurchases (USD) 2025-12-31
Period endedShare RepurchasesChange YoYSource filing
2025-12-31$13.76Mn/a2026-03-12, From 2025-01-01
No annual figure between 2023-12-31 and 2025-12-31.
2023-12-31$13.96Mn/a2025-03-18, From 2023-01-01

Share Repurchases at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShare RepurchasesChange YoY
Tonix Pharmaceuticals Holding Corp. (TNXP)2025-12-31$13.76Mn/a
Roivant Sciences Ltd. (ROIV)2025-03-31$1.29Bn/a
Alumis Inc. (ALMS)2025-12-31$17.0K+183.3%
Earth Science Tech, Inc. (ETST)2026-03-31$471.4K-67.8%
Sunshine Biopharma Inc. (SBFM)2025-12-31$0-100.0%
Lftd Partners Inc. (LIFD)2025-12-31$0-100.0%
ProPhase Labs, Inc. (PRPH)2024-12-31$0-100.0%
Cumberland Pharmaceuticals Inc (CPIX)2025-12-31$263.5K-54.5%
Lexicon Pharmaceuticals, Inc. (LXRX)2024-12-31$1.73M+110.0%

Compare TNXP, ROIV, ALMS, ETST side by side · Screen every company in Pharmaceutical Preparations ↗